690
J. L. García Ruano et al.
PAPER
3.30 (m, 1 H), 2.35 (s, 3 H), 2.28 (s, 3 H), 2.12 (m, 1 H), 1.99 (m, 1
H), 1.89 (m, 1 H), 1.75 (m, 1 H), 1.64 (m, 1 H), 1.10–0.80 (m, 23 H).
(2R,1¢S)-(1¢-Phenyl-1¢-triisopropylsilyloxymethyl)piperidine-N-
(R)-MTPA Amide (12b)
Prepared from 10; yield: 76%; yellow oil.
13C NMR: d = 143.2, 142.4, 141.4, 140.9, 140.7 (2 C), 131.2, 129.9,
129.2, 129.1, 128.9, 125.8, 125.7, 125.1, 71.4, 69.2, 41.3, 28.7,
25.1, 21.2, 18.0, 17.8, 12.5.
1H NMR: d = 7.52–7.35 (m, 5 H), 7.20 (tt, J = 7.7, 1.0 Hz, 1 H), 7.04
(t, J = 8.31 Hz, 2 H), 6.46 (d, J = 7.7 Hz, 2 H), 5.15 (m, 1 H), 4.95
(d, J = 9.5 Hz, 1 H), 3.68 (s, 3 H), 3.41 (m, 2 H), 2.30 (m, 2 H),
1.75–1.40 (m 4 H), 1.1–0.8 (m, 21 H).
MS (FAB): m/z (%) = 610 (M + 1, 12), 470 (100), 385 (42), 334
(70), 211 (30), 160 (74).
HRMS-FAB: m/z calcd for C34H47NO3S2Si [M + H]+: 610.2767;
found: 610.2855.
(2R,1¢S)-(1¢-Phenyl-1¢-triisopropylsilyloxymethyl)pyrrolidine-
N-(S)-MTPA Amide (13a)
Prepared from 11; yield: 55%; yellow oil.
Double Desulfinylation; General Procedure
1H NMR: d = 7.52–7.35 (m, 10 H), 5.65 (d, J = 1.9 Hz, 1 H), 4.22
(td, J = 7.5, 1.9 Hz, 1 H), 3.70 (s, 3 H), 3.53 (m, 1 H), 3.22 (m, 2 H),
2.28 (m, 1 H), 1.69 (m, 1 H), 1.47 (m, 1 H), 1.10–0.80 (m, 21 H).
To a stirred solution of 7 or 9 (0.2 mmol) in THF (2 mL) was added
a suspension of activated Raney-nickel (1.2 g). The reaction was
stirred 2 h, and then the crude product was purified by SCX column
to afford the amine.
(2R,1¢S)-(1¢-Phenyl-1¢-triisopropylsilyloxymethyl)pyrrolidine-
N-(R)-MTPA Amide (13b)
Prepared from 11; yield: 55%; yellow oil.
1H NMR: d = 7.60–7.21 (m, 10 H), 5.44 (d, J = 2.2 Hz, 1 H), 4.22
(td, J = 6.2, 2.2 Hz, 1 H), 3.60 (m, 2 H), 3.54 (s, 3 H), 3.41 (m, 1 H),
2.54 (m, 1 H), 2.15 (m, 1 H), 1.80–1.70 (m, 1 H), 1.20–0.80 (m, 21
H).
(2R,1¢S)-(1¢-Phenyl-1¢-triisopropylsilyloxymethyl)piperidine
(10)
Yield: 77%; colorless oil; [a]D20 +22.9 (c = 0.4, CHCl3).
IR (film): 3583, 3416, 2942, 1601, 1462, 1198 cm–1.
1H NMR: d = 7.45–7.20 (m, 5 H), 4.72 (d, J = 6.5 Hz, 1 H), 3.58 (br
s, 1 H), 3.13 (m, 1 H), 2.74 (m, 1 H), 2.55 (td, J = 8.9, 2.4 Hz, 1 H),
1.99 (m, 1 H), 1.85 (m, 1 H), 1.60–1.30 (m, 4 H), 1.10–0.90 (m, 21
H).
13C NMR: d = 141.8, 128.2, 127.9, 127.4, 78.1, 63.5, 46.8, 27.7,
25.3, 24.1, 18.0, 17.9, 12.4.
(1R,2S¢)-a-(Pyrrolidin-2-yl)benzyl Alcohol (1)23
A solution of compound 11 (31 mg, 0.1 mmol) in CH2Cl2 (2 mL)
was treated with a 1 M solution of NBu4F (100 mL, 1.2 mmol). After
stirring the mixture for 3 h at r.t., the solvent was evaporated. The
residue was extracted with CH2Cl2 (4 mL), and washed with H2O
(2 × 10 mL). The aqueous phase was treated with NaOH (5 mL)
and extracted with EtOAc (3 × 5 mL). The solvent was dried and
removed under reduced pressure, affording the corresponding
alcohol; yield: 16 mg (91%); [a]D20 +55.0 (c = 0.90, MeOH)
{enantiomer of 1; Lit.23 [a]D20 +56.9 (c = 0.98, MeOH)}.
MS (FAB): m/z (%) = 348 (M + 1, 100) 174 (94), 84 (42).
HRMS-FAB: m/z calcd for C21H38NOSi [M + H]+: 348.2722;
found: 348.2738.
(2R,1¢S)-(1¢-Phenyl-1¢-triisopropylsilyloxymethyl)pyrrolidine
(11)
Yield: 79%; colorless oil; [a]D20 +30.2 (c = 0.3, MeOH).
(1R,2S¢)-a-(Piperidin-2-yl)benzyl Alcohol (2)23
A solution of compound 10 (33 mg, 0.1 mmol) in CH2Cl2 (2 mL)
was treated with a 1 M solution of NBu4F (100 mL, 1.2 mmol). After
stirring the mixture for 3 h at r.t., the solvent was evaporated. The
residue was extracted with CH2Cl2 (4 mL), and washed with H2O
(2 × 10 mL). The aqueous phase was treated with NaOH (5 mL)
and extracted with EtOAc (3 × 5 mL). The solvent was dried and
removed under reduced pressure, affording the corresponding
alcohol; yield: 18 mg (95%); [a]D20 +20.0 (c = 1.00, H2O)
{enantiomer of 1; Lit.23 [a]D20 –22.0 (c = 1.30, H2O)}.
IR (film): 3420, 2944, 1456 cm–1.
1H NMR: d = 7.48 (d, J = 8.2 Hz, 2 H), 7.33 (m, 3 H), 5.05 (d,
J = 6.1 Hz, 1 H), 3.69 (m, 1 H), 3.07 (m, 1 H), 2.30–1.80 (m, 5 H),
1.20–0.90 (m, 21 H).
13C NMR: d = 140.3, 128.6, 128.3, 127.3, 74.8, 65.6, 46.0, 27.2,
23.7, 18.0, 12.4.
Anal. Calcd for C20H35NOSi: C, 72.01; H, 10.58; N, 4.20. Found: C,
72.20; H, 10.48; N, 4.40.
MTPA Amides of 10 and 11; General Procedure
Acknowledgment
A solution of compound 10 or 11 (0.01 mmol) in CH2Cl2 (1 mL)
was added to Et3N (5 mL, 0.02 mmol) and (S)-MTPA-Cl or (R)-
MTPA-Cl under argon (6 mL, 0.02 mmol). When the reaction was
complete, the mixture was hydrolyzed with 5% HCl (1 mL), and ex-
tracted with CH2Cl2 (3 × 1 mL). The combined organic extracts
were washed with sat. aq NaHCO3 (2 × 2 mL), dried (Na2SO4) and
the solvent evaporated. The residue was purified by flash column
chromatography (EtOAc–hexane, 1:15).
We thank the Spanish Government for financial support (Grant
BQU2003-4012). J.A. and M.B.C. thank the Ministerio de Ciencia
y Tecnología for a predoctoral fellowship and Ramón y Cajal con-
tract, respectively.
References
(1) For synthesis of substituted pyrrolidines, see: (a) Hill, K. R.
Chemistry of the Alkaloids; Pelletier, S. W., Ed.; Van
Nostren Reinhold: New York, 1970, 385. (b) Baliah, V.;
Jeyaramna, R.; Chandrasekara, L. Chem. Rev. 1983, 83,
379. (c) Wang, C. J. J.; Wuonola, M. A. Org. Prep. Proced.
Int. 1992, 24, 583. (d) Pichon, M.; Figadere, B.
(2R,1¢S)-(1¢-Phenyl-1¢-triisopropylsilyloxymethyl)piperidine-N-
(S)-MTPA Amide (12a)
Prepared from 10; yield: 66%; yellow oil.
1H NMR: d = 7.52–7.20 (m, 10 H), 5.16 (m, 1 H), 4.98 (d, J = 9.6
Hz, 1 H), 3.68 (m, 1 H), 3.42 (m, 1 H), 2.66 (td, J = 13.3, 2.8 Hz, 1
H), 2.43 (s, 3 H), 2.20 (m, 1 H), 1.75–1.40 (m 4 H), 1.10–0.80 (m,
21 H).
Tetrahedron: Asymmetry 1996, 7, 927. (e) Dewick, P. M.
Medicinal Natural Products; Wiley: Chichester, 1997,
Chap. 6. (f) Laschat, S. Liebigs Ann. 1997, 1. (g) Bailey, P.
D.; Millwood, P. A.; Smith, P. D. Chem. Commun. 1998,
Synthesis 2006, No. 4, 687–691 © Thieme Stuttgart · New York